Cadent Therapeutics
Latest round
- Series B
Last raised
- Apr 2020
Total raised
- $53M
Investors
- 8
About Cadent Therapeutics
Cadent Therapeutics, Inc.Cadent Therapeutics, Inc. specializes in the development of therapies for neuropsychiatric disorders. The company was founded in 2010 and is headquartered in Cambridge, US. The acquisition is anticipated to close in the first quarter of 2021.Cadent Therapeutics offers several innovative therapies targeting significant medical needs in neuropsychiatric disorders. These include MIJ821, a clinical-stage molecule designed for treatment-resistant depression, and CAD-9303, which addresses the negative and cognitive symptoms of schizophrenia. Additionally, CAD-1883 is in Phase II development for movement disorders.Cadent Therapeutics generates revenue through product sales to healthcare providers and strategic partnerships with other pharmaceutical companies. Its revenue model includes direct sales of proprietary therapies, as well as collaboration agreements encompassing upfront payments, royalties, and further sales contingent on market success.Cadent Therapeutics plans to leverage its recent acquisition by Novartis International AG to accelerate the development of its innovative therapies. The company aims to launch new products targeting various neuropsychiatric disorders in the coming years, with specific timelines dependent on ongoing clinical trials. Cadent is also looking to expand its market presence into new geographic regions, particularly within Europe and Asia by the end of 2021.
Who invested in Cadent Therapeutics
8 investors across 6 rounds
See all investors in Cadent Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Cadent Therapeutics
Who invested in Cadent Therapeutics?
Cadent Therapeutics has 8 investors on record across 6 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Cadent Therapeutics raised?
Cadent Therapeutics has raised 6 venture rounds. Sign up free to see how much each round raised and the total.
When did Cadent Therapeutics last raise money?
Cadent Therapeutics's most recent round on record is a Series B, in Apr 2020.
What does Cadent Therapeutics do?
Cadent Therapeutics is a biotechnology company.
Where is Cadent Therapeutics headquartered?
Cadent Therapeutics is headquartered in Cambridge, US.
Which VCs invest in companies like Cadent Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Cadent Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Cadent Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.